Andere talen Bioventus Inc.

Aandelen

BVS

US09075A1088

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,98 ^USD	-2,21%		-11,16%	-24,48%

13/03	BIOVENTUS INC. : Craig-Hallum handhaaft koopadvies	ZM
12/03	Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bioventus : Q4’23 Earnings Call Slides	12/03
Earnings Flash (BVS) BIOVENTUS Posts Q4 Revenue $135.4M	12/03
Earnings Flash (BVS) BIOVENTUS Reports Q4 EPS $0.07	12/03
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	12/03
Bioventus Inc. Provides Earnings Guidance for the Year 2024	12/03
Bioventus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Bioventus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
North American Morning Briefing : Inflation Data -2-	12/03
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	04/03
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	18/01
Bioventus Inc. Enters into an Amendment with Its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	18/01
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	12/01
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	27/12
Bioventus Hires Robert Claypoole as Chief Executive	20/12
Bioventus Names Robert Claypoole as President and Chief Executive Officer	19/12
Bioventus Inc Announces Executive Changes	19/12
Bioventus Inc. Announces Executive Changes	19/12
North American Morning Briefing : Futures Pause -2-	08/12
Bioventus Contract With Aetna to Give Medicare Advantage Plan Members Access to Durolane for Knee Osteoarthritis Pain	06/12
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis	06/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bioventus Inc.

Aandelen

BVS

US09075A1088

Andere talen

Filters